ATE329586T1 - COMPOSITIONS CONTAINING CAROTENOIDS AND THEIR USE FOR PREVENTING HORMONE-INDUCED SIDE EFFECTS - Google Patents
COMPOSITIONS CONTAINING CAROTENOIDS AND THEIR USE FOR PREVENTING HORMONE-INDUCED SIDE EFFECTSInfo
- Publication number
- ATE329586T1 ATE329586T1 AT01917436T AT01917436T ATE329586T1 AT E329586 T1 ATE329586 T1 AT E329586T1 AT 01917436 T AT01917436 T AT 01917436T AT 01917436 T AT01917436 T AT 01917436T AT E329586 T1 ATE329586 T1 AT E329586T1
- Authority
- AT
- Austria
- Prior art keywords
- adverse effects
- administration
- hormone
- side effects
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A method for preventing the adverse effects which may he associated with the administration of at least one hormone to a subject without detectable cancer comprising administering to such subject at least one carotenoid. The method of the instant invention can be utilized to prevent a variety of adverse effects associated with the administration of hormones, including for example, an increased risk for developing cancer. The instantly claimed method prevents such adverse effects without inhibiting the beneficial activity of the hormone. Further provided by the present invention are compositions which are useful for preventing the adverse effects associated with the administration of hormones. The compositions of the instant invention may be in unit dosage form suitable for daily administration to a human.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL135335A IL135335A (en) | 2000-03-29 | 2000-03-29 | Use of carotenoids in the preparation of medicaments for preventing hormone induced adverse effects and pharmaceutical compositions comprising carotenoids |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE329586T1 true ATE329586T1 (en) | 2006-07-15 |
Family
ID=11073993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01917436T ATE329586T1 (en) | 2000-03-29 | 2001-03-28 | COMPOSITIONS CONTAINING CAROTENOIDS AND THEIR USE FOR PREVENTING HORMONE-INDUCED SIDE EFFECTS |
Country Status (16)
Country | Link |
---|---|
US (4) | US20010027216A1 (en) |
EP (1) | EP1267851B1 (en) |
JP (1) | JP5020455B2 (en) |
KR (1) | KR100818973B1 (en) |
CN (1) | CN1434707A (en) |
AT (1) | ATE329586T1 (en) |
AU (2) | AU4451101A (en) |
BR (1) | BR0107535A (en) |
CA (1) | CA2404097A1 (en) |
DE (1) | DE60120659T2 (en) |
ES (1) | ES2262635T3 (en) |
IL (1) | IL135335A (en) |
NO (1) | NO20024586L (en) |
RU (1) | RU2002125508A (en) |
SE (1) | SE0202857D0 (en) |
WO (1) | WO2001078701A2 (en) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146449A0 (en) * | 2001-11-12 | 2002-07-25 | Lycored Natural Prod Ind Ltd | Method and pharmaceutical preparations for reducing the activity of cells |
JP2006516396A (en) * | 2003-01-31 | 2006-07-06 | デーエスエム アイピー アセッツ ベー. ヴェー. | Novel compositions containing carotenoids |
US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
US8521284B2 (en) | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
KR100739531B1 (en) | 2004-05-07 | 2007-07-13 | 주식회사 이오텍 | Compositions Comprising Lycopene and Phytoestrogen |
US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
JP2006069910A (en) * | 2004-08-31 | 2006-03-16 | Yoshiichi Sugimoto | Anticancer agent-resistance overcoming agent |
US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7457664B2 (en) | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
US7805185B2 (en) | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7392086B2 (en) | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
US20080004665A1 (en) * | 2006-06-29 | 2008-01-03 | Mccabe Aaron R | Determination of cardiac pacing parameters based on non-localized sensing |
US8209013B2 (en) | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
AU2009214920B2 (en) | 2008-02-14 | 2012-02-09 | Cardiac Pacemakers, Inc. | Method and apparatus for phrenic stimulation detection |
WO2010042364A2 (en) | 2008-10-06 | 2010-04-15 | Cardiac Pacemakers, Inc. | Dynamic cardiac resynchronization therapy by tracking intrinsic conduction |
PT2782584T (en) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
JP2017516768A (en) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | Natural combination hormone replacement therapy and therapy |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US9669006B2 (en) | 2015-07-28 | 2017-06-06 | U.S. Nutraceuticals, LLC | Composition and method to treat and alleviate symptoms of hot flashes in a female subject |
KR20180126582A (en) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN114300088B (en) * | 2021-12-15 | 2023-06-16 | 苏州大学附属第二医院 | Body temperature monitoring device and system for guiding perimenopausal hormone replacement therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3833350A (en) * | 1972-12-14 | 1974-09-03 | Amchem Prod | Method of inducing carotenoid accumulation in plant tissue |
US5422119A (en) * | 1987-09-24 | 1995-06-06 | Jencap Research Ltd. | Transdermal hormone replacement therapy |
US6132790A (en) | 1991-09-06 | 2000-10-17 | Betatene Limited | Carotenoid composition |
NZ252051A (en) | 1992-05-19 | 1996-10-28 | Graham Edmund Kelly | Health supplement comprising a phyto-oestrogen selected from genistein, daidzein, biochanin and/or formononetin |
IL103920A (en) | 1992-11-30 | 2000-07-26 | Makhteshim Chem Works Ltd | Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof |
WO1994023716A1 (en) * | 1993-04-16 | 1994-10-27 | Tufts University School Of Medicine | Method for treatment of menopausal and premenstrual symptoms |
US6218436B1 (en) | 1993-06-28 | 2001-04-17 | The Howard Foundation | Pharmaceutically active carotenoids |
US5424331A (en) * | 1994-06-10 | 1995-06-13 | Bio-Virus Research Incorporated | Pharmaceutical compositions and dietary soybean food products for the prevention of osteoporosis |
US5475006A (en) | 1994-08-10 | 1995-12-12 | National Research Council Of Canada | Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-differentiation inducers, anti-proliferative agents, and anti-tumor agents |
US5516528A (en) | 1995-01-13 | 1996-05-14 | Wake Forest University | Dietary phytoestrogen in estrogen replacement therapy |
US5643623A (en) | 1995-06-07 | 1997-07-01 | Mars Incorporated | Health food product and its uses |
US5807586A (en) * | 1996-07-30 | 1998-09-15 | Energetics, Inc. | Method of dietary supplementation |
US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
US6013665A (en) * | 1997-12-16 | 2000-01-11 | Abbott Laboratories | Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
IL129442A0 (en) | 1999-04-14 | 2000-02-29 | Lycored Natural Prod Ind Ltd | Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood |
AU1135701A (en) | 1999-10-14 | 2001-04-23 | Schroeder, Fritz H. | Compositions with anti-prostate cancer activity |
-
2000
- 2000-03-29 IL IL135335A patent/IL135335A/en not_active IP Right Cessation
-
2001
- 2001-03-05 US US09/799,140 patent/US20010027216A1/en not_active Abandoned
- 2001-03-05 US US09/799,251 patent/US7144586B2/en not_active Expired - Lifetime
- 2001-03-28 CA CA002404097A patent/CA2404097A1/en not_active Abandoned
- 2001-03-28 DE DE60120659T patent/DE60120659T2/en not_active Expired - Lifetime
- 2001-03-28 RU RU2002125508/14A patent/RU2002125508A/en unknown
- 2001-03-28 ES ES01917436T patent/ES2262635T3/en not_active Expired - Lifetime
- 2001-03-28 BR BR0107535-7A patent/BR0107535A/en not_active Application Discontinuation
- 2001-03-28 KR KR1020027012651A patent/KR100818973B1/en not_active IP Right Cessation
- 2001-03-28 AU AU4451101A patent/AU4451101A/en active Pending
- 2001-03-28 CN CN01810131A patent/CN1434707A/en active Pending
- 2001-03-28 US US10/240,090 patent/US8669293B2/en not_active Expired - Fee Related
- 2001-03-28 JP JP2001576002A patent/JP5020455B2/en not_active Expired - Fee Related
- 2001-03-28 AT AT01917436T patent/ATE329586T1/en not_active IP Right Cessation
- 2001-03-28 WO PCT/IL2001/000291 patent/WO2001078701A2/en active IP Right Grant
- 2001-03-28 EP EP01917436A patent/EP1267851B1/en not_active Expired - Lifetime
- 2001-03-28 AU AU2001244511A patent/AU2001244511B2/en not_active Ceased
-
2002
- 2002-09-25 NO NO20024586A patent/NO20024586L/en unknown
- 2002-09-27 SE SE0202857A patent/SE0202857D0/en unknown
-
2004
- 2004-04-16 US US10/825,434 patent/US20040198674A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2262635T3 (en) | 2006-12-01 |
EP1267851A2 (en) | 2003-01-02 |
WO2001078701A3 (en) | 2002-07-25 |
EP1267851B1 (en) | 2006-06-14 |
KR20020093858A (en) | 2002-12-16 |
NO20024586D0 (en) | 2002-09-25 |
JP2003530428A (en) | 2003-10-14 |
JP5020455B2 (en) | 2012-09-05 |
KR100818973B1 (en) | 2008-04-04 |
SE0202857D0 (en) | 2002-09-27 |
DE60120659T2 (en) | 2007-06-06 |
US20030148946A1 (en) | 2003-08-07 |
IL135335A (en) | 2013-12-31 |
US20030004146A1 (en) | 2003-01-02 |
IL135335A0 (en) | 2001-05-20 |
US20040198674A1 (en) | 2004-10-07 |
CN1434707A (en) | 2003-08-06 |
DE60120659D1 (en) | 2006-07-27 |
US7144586B2 (en) | 2006-12-05 |
CA2404097A1 (en) | 2001-10-25 |
AU4451101A (en) | 2001-10-30 |
US8669293B2 (en) | 2014-03-11 |
AU2001244511B2 (en) | 2006-04-27 |
BR0107535A (en) | 2005-05-03 |
WO2001078701A2 (en) | 2001-10-25 |
RU2002125508A (en) | 2004-03-20 |
US20010027216A1 (en) | 2001-10-04 |
NO20024586L (en) | 2002-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE329586T1 (en) | COMPOSITIONS CONTAINING CAROTENOIDS AND THEIR USE FOR PREVENTING HORMONE-INDUCED SIDE EFFECTS | |
HK1100480A1 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
BR0106681A (en) | Pediatric formula and methods for providing nutrition to pediatric patients and improving tolerance in pediatric patients. | |
DE602004027936D1 (en) | TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND | |
HK1097449A1 (en) | Methods for in vivo delivery of biologics and compositions useful therefor | |
BR0214343A (en) | 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1 | |
DE69533112D1 (en) | USE OF FLAVOLIGNANES FOR THE PRODUCTION OF MEDICINES WITH ANTIPROLIFERATIVE ACTIVITY IN UTERUS, BREAST, EGGS | |
DE60027575D1 (en) | Use of spinosad or a composition containing spinosad | |
CY1107906T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING OSTETROL PRODUCTS FOR USE IN CANCER TREATMENT | |
AR021370A1 (en) | STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS CONTAINING TAXOID ANTI-NEOPLASIC AGENTS | |
DE60019334D1 (en) | ANTIVIRAL ARZNEI | |
BR0207443A (en) | Method and dosage form for the treatment of tumors by administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin | |
HK1085927A1 (en) | The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes | |
HUP0203197A2 (en) | Use of docetaxel for treating hepatocellular carcinoma | |
DE60329968D1 (en) | Dosage forms containing thyroid hormones and their method of preparation | |
MXPA05006081A (en) | COMPOUNDS WHICH MODULATE PPARgamma TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS. | |
AR040287A1 (en) | PLATFORM FOR TRANSDERMAL FORMULATIONS (PFT) | |
TR200200987T2 (en) | Substituted pyrroles for cancer treatment | |
MD1780G2 (en) | Method of treatment of patients with hepatic cirrhosis | |
LT2001072A (en) | Food additive | |
BR0312283A (en) | A combination comprising an alkylating agent and a vegf activity reducing agent | |
DE50304524D1 (en) | DRUGS INCLUDED SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLE | |
UA41154A (en) | Germogran-m composition based on oil from wheat germs | |
UA41089A (en) | Method for preventing iodine deficiency in children | |
UA6855U (en) | Method for treating myoma of uterus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |